BioPharma Pharma Research
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a...
July 04, 2025 | News
Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and...
July 02, 2025 | News
AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapie...
July 02, 2025 | News
WuXi XDC Cayman Inc, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced...
July 02, 2025 | News
Alpha Fusion, Inc. ("Alpha Fusion") and Curadh MTR Inc. ("Curadh") announced plans to enter a strategic partnership, including a Joint Venture t...
July 01, 2025 | News
XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking m...
June 30, 2025 | News
Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today anno...
June 27, 2025 | News
Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic coll...
June 25, 2025 | News
Expanding track record by signing contracts with various global companies across Asia and Europe LOTTE BIOLOGICS announced on June 19, 2025 that it ha...
June 19, 2025 | News
Extended campus at headquarters of French sub-group Sartorius Stedim Biotech in Aubagne Significantly increased capacities for manufacturing, logistics,...
June 19, 2025 | News
BioDlink's Bevacizumab Injection has been granted marketing authorization by Nigeria's National Agency for Food and Drug Administration an...
June 17, 2025 | News
Abbisko Therapeutics announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective ...
June 17, 2025 | News
MOBILIZE-1 is the first Phase 3 study being initiated for V181 as part of a planned robust clinical development program Study will evaluate a single dos...
June 16, 2025 | News
Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the expansion of its existing supply and distribution agree...
June 13, 2025 | News
Most Read
Bio Jobs
News
Editor Picks